Friday's TechBio News 📰
The week’s TechBio roundup highlighted a surge of AI‑driven collaborations and funding across biotech. Lundbeck teamed with Cradle to launch two CNS antibody programs using generative AI, while Alnylam inked a $2 billion deal with Inceptive to accelerate RNAi discovery. XtalPi reported IND‑enabling progress on a multi‑cancer asset with DoveTree, and early‑stage firms Apoha and Lightcast raised $36 million and $27 million respectively to commercialize novel data and single‑cell platforms. These moves underscore the accelerating convergence of artificial intelligence and drug development.
Monday's TechBio News
Monday’s TechBio roundup highlights a wave of AI‑driven biotech financing and strategic collaborations. European‑origin startups such as Perceptic (formerly £9 million, ≈$11.5 million) and Living Models secured $12 million and $7 million seed rounds respectively, while U.S.‑based Iterative Health closed a $77 million Series C to...
Applying AI to Biomedical Imaging (II)
The second installment of the "Applying AI to Biomedical Imaging" newsletter curates the latest developments across the United States, Europe, the Middle East, the Far East, and Russia. It highlights new AI-driven imaging tools, regulatory milestones, and cross‑border collaborations that...
Latest TechBio News
A wave of AI‑driven partnerships and funding rounds is reshaping drug discovery, from Insilico Medicine’s collaboration with Ribo on automated oligonucleotide research to LenioBio‑Twist’s 24‑hour cell‑free protein platform. AstraZeneca deepened its Immunai alliance, while Simulations Plus joined forces with NVIDIA...
Applying AI to Biomedical Imaging (I)
Euro-BioImaging received Horizon Europe funding to coordinate 12 AI‑driven imaging projects across Europe, bolstering training, data FAIRness, and pandemic preparedness. The AI4Life Model Evaluation Platform now offers side‑by‑side benchmarking of microscopy models, while the EUCANIMAGE partnership aims to build a...
Your Weekly TechBio News: High-Throughput Screening
High‑Throughput Screening (HTS) remains a cornerstone of modern drug discovery, allowing researchers to evaluate millions of chemical compounds against biological targets in a single campaign. Recent advances in robotics, miniaturized assay formats, and cloud‑based data pipelines have dramatically increased throughput...
Chemistry & Materials 🧪 Techbio News
Mstack AI launched Chemstack AI, the first closed‑loop AI ecosystem that unifies the entire chemical lifecycle—from literature mining to laboratory experimentation. The platform claims to shrink synthesis and commercialization timelines from the traditional 18 months to a matter of days, delivering...
Major Organoids Companies Plus Latest TechBio News
The latest TechBio briefing spotlights the fastest‑growing private organoid firms, highlighting recent Series A‑C rounds that collectively raised over $500 million. Leaders such as OrganoTech, CellSphere, and BioMimic are scaling production pipelines to meet demand from pharma, diagnostics, and personalized‑medicine partners. The...
Latest TechBio News
Evotec SE announced that its Seattle CDMO, Just‑Evotec Biologics, has been selected by BARDA’s BioMaP‑Consortium for a multi‑year, up‑to‑$10 million program to optimize manufacturing of a monoclonal‑antibody cocktail against Ebola and Sudan viruses. The same day, Evotec disclosed that partner Bristol...
Brain TechBio 🧠🖥️ (ΙIΙ)
The latest Brain TechBio roundup highlights several breakthroughs across neurotechnology and AI-driven drug discovery. Angelini Pharma has inked a multi‑year deal with Quiver Bioscience, offering up to $120 million in milestones for AI‑guided epilepsy treatments. In India, KIMS Hospitals introduced adaptive...
Latest TechBio News
Proscia has been crowned the top‑performing digital pathology software vendor in the United States, receiving a 95.2 overall score in KLAS Research’s 2026 report and earning A+ or A grades across all six customer‑experience pillars. The company is also the...
Organoids and Artificial Intelligence 🫐
The episode explores the rapid convergence of organoid technology and artificial intelligence, highlighting how AI-driven image analysis, multidimensional data integration, and high‑throughput screening are transforming organoid research. It introduces the emerging field of Organoid Intelligence, where brain organoids act as...
Latest on TechBio News
The episode highlights Proscia’s recent achievements, including being named the Global 2026 Best in KLAS for Digital Pathology in Europe and a series of product and partnership milestones such as new AI tools for skin biomarkers, virtual staining, and integration...
Blood Glucose Monitoring
The episode explores how AI and machine learning are reshaping blood glucose monitoring, moving from invasive blood draws toward non‑invasive analysis of sweat, saliva, and interstitial fluid. It highlights advances such as Raman spectroscopy combined with AI to interpret complex...
Weekly TechBio News 🌟🎄
This episode highlights four major tech‑bio developments: Egypt’s Nawah Scientific secured $23 million to expand its remote "cloud lab" platform into Rwanda and Saudi Arabia while scaling operations in Egypt; UpCloud opened a new data center in Copenhagen to boost low‑latency...